Physician

David C Kay, M.D.

According to 2025 Medicare claims, David Kay, M.D. (NPI: 1073586335) practices internal medicine in the Elkhart-Goshen, IN market, with the plurality of this provider's patient population coming from Elkhart, IN. This provider's primary affiliated billing organization is GOSHEN HEALTH SYSTEM INC (NPI: 1194772293; TIN: 35-1974765) and primary practice location at 46526-6546. Kay is affiliated with the Indiana Lakes ACO (ACO ID: A1494), participating under the MSSP model.

Kay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 590 traditional Medicare patients, billed 2,635 HCPCS/CPT codes, and received $165,226 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 12,190 prescription claims across 768 beneficiaries totaling $926,302 in drug costs, led by Eliquis (Apixaban). DME data shows 396 claims. Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	887	4,717	$187,987
2016	823	5,482	$224,923
2017	850	5,802	$218,468
2018	811	7,531	$237,628
2019	797	6,586	$215,833
2020	702	4,683	$168,141
2021	678	4,685	$190,548
2022	620	4,334	$203,521
2023	633	3,342	$182,275
2024	590	2,635	$165,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	879	14,721	$861,868
2016	849	13,852	$879,680
2017	795	13,114	$895,012
2018	750	12,306	$936,399
2019	759	11,800	$906,045
2020	773	11,904	$916,735
2021	813	11,354	$908,900
2022	865	11,881	$1,003,734
2023	853	11,522	$1,193,181
2024	768	12,190	$926,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	218	1,075	$45,227
2016	269	1,001	$34,316
2017	214	796	$30,246
2018	175	749	$40,867
2019	213	840	$45,463
2020	94	556	$28,122
2021	112	589	$44,907
2022	151	559	$44,001
2023	112	502	$35,576
2024	56	396	$29,862

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	291	291	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	826	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	161	233	$55
83036	Hemoglobin a1c level	100	191	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	134	189	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	190	8,581	$169,240
Januvia	Sitagliptin Phosphate	66	4,830	$89,332
Ozempic	Semaglutide	71	3,043	$87,774
Jardiance	Empagliflozin	67	3,472	$69,601
Xarelto	Rivaroxaban	20	1,440	$26,651

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	39	$15,750
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	13	$4,854
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	55	$4,099
A7031	Face mask interface, replacement for full face mask, each	N	N/R	12	$817
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	34	$802

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$19	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David C. Kay, M.D.?

Tedicare shows public-source Medicare data for David C. Kay, M.D. (NPI 1073586335), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David C. Kay, M.D. have ACO affiliation data?

David C. Kay, M.D. is shown with ACO affiliation data for Indiana Lakes ACO (MSSP, ACO ID A1494).

What billing organization is linked to David C. Kay, M.D.?

David C. Kay, M.D. is linked to GOSHEN HEALTH SYSTEM INC (billing NPI 1194772293) in the available physician profile data.

Does David C. Kay, M.D. have Open Payments data?

David C. Kay, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.